ALPRE Predilife S.A.
0.5496USD0.5000 EUR · EPA-4.21%Mkt Cap: 2.17M USDP/E: —1d ago
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. It provides breast cancer predictive assessment; and multi-pathology predictive assessment. The company also offers MammoRisk, a breast cancer prediction test based on the patient's individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.…